Biotechnology and Injectable Drug Advisor (BIDA) aims to address manufacturers’ emerging need to effectively track the dispensing of specialized and injectable drugs by utilizing medical and prescription claims activity to measure the sale and utilization of drugs. For drugs with multiple indications, the BIDA solution tracks injectable drug sales by diagnoses, which helps to align budgeting, segmentation and targeting, profiling and promotional messaging with pharmaceutical sales and marketing strategies.
BIDA is yet another example of our ability to leverage data gathered from our NDCHealth Intelligent Network to deliver to the pharmaceutical industry much needed next generation solutions offering multiple healthcare channel views, said Walter Hoff, chairman and CEO, NDCHealth. Through our unique role at the center of healthcare, NDCHealth continues to offer our customers unique and powerful insights into the marketplace, as well as tools to enable them to respond quickly and effectively.
